Literature DB >> 463530

The protective effect of acute phase reactants in neonatal sepsis.

A G Philip.   

Abstract

Phase reactants were evaluated prospectively in babies suspected of having sepsis. Among 318 babies, there were 22 proven and 10 "very probable" cases of neonatal sepsis. Of the proven cases 14 survived and 8 died. The survivors had a positive latex C-reactive protein (CRP) in 11 cases and an alpha1-acid glycoprotein (AGP) level greater than 0.5 g/l in 12 cases. Among those who died, one had a positive latex CRP and none had AGP greater than 0.5 g/l. These findings were supported by positive CRP and elevated AGP in almost all "very probable" cases, all of whom survived. These data in newborn infants support the hypothesis that acute phase reactants have a functional role in combating infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 463530     DOI: 10.1111/j.1651-2227.1979.tb05044.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  5 in total

1.  Acute phase proteins for diagnosis and follow-up of neonatal infections.

Authors:  L Sann
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

2.  Amniotic fluid interleukin 6 in preterm labor. Association with infection.

Authors:  R Romero; C Avila; U Santhanam; P B Sehgal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Diagnostic audit of C-reactive protein in neonatal infection.

Authors:  N J Mathers; F Pohlandt
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

4.  Plasma C-reactive protein levels are associated with improved outcome in ARDS.

Authors:  Ednan K Bajwa; Uzma A Khan; James L Januzzi; Michelle N Gong; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2009-05-01       Impact factor: 9.410

5.  Serum orosomucoid concentration in newborn infants.

Authors:  L Sann; J Bienvenu; C Lahet; P Divry; J Cotte; M Bethenod
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.